Aetna CEO Sells $8,868,918 in Stock (AET)
Aetna (NYSE:AET) CEO Mark Bertolini unloaded 130,272 shares of the stock in a transaction that occurred on Monday, December 30th. The shares were sold at an average price of $68.08, for a total value of $8,868,917.76. Following the completion of the sale, the chief executive officer now directly owns 526,938 shares in the company, valued at approximately $35,873,939. The sale was disclosed in a filing with the SEC, which is available at this link.
Aetna (NYSE:AET) traded down 1.50% on Thursday, hitting $67.56. 1,650,687 shares of the company’s stock traded hands. Aetna has a 1-year low of $44.38 and a 1-year high of $69.47. The stock’s 50-day moving average is $66.64 and its 200-day moving average is $64.51. The company has a market cap of $24.828 billion and a P/E ratio of 13.87. Aetna also was the target of unusually large options trading on Tuesday. Stock investors purchased 7,517 call options on the stock. This represents an increase of 486% compared to the typical volume of 1,283 call options.
Aetna (NYSE:AET) last posted its quarterly earnings results on Tuesday, October 29th. The company reported $1.53 EPS for the quarter, meeting the Thomson Reuters consensus estimate of $1.53. The company had revenue of $12.99 billion for the quarter, compared to the consensus estimate of $12.89 billion. During the same quarter last year, the company posted $1.55 earnings per share. Aetna’s revenue was up 46.0% compared to the same quarter last year. On average, analysts predict that Aetna will post $5.87 earnings per share for the current fiscal year.
The company also recently declared a quarterly dividend, which is scheduled for Friday, January 31st. Investors of record on Thursday, January 16th will be given a dividend of 0.225 per share. This represents a $0.90 dividend on an annualized basis and a yield of 1.33%. The ex-dividend date of this dividend is Tuesday, January 14th. This is an increase from Aetna’s previous quarterly dividend of $0.20.
A number of research firms have recently commented on AET. Analysts at FBR Capital Markets raised their price target on shares of Aetna from $71.00 to $75.00 in a research note to investors on Friday, December 13th. They now have an “outperform” rating on the stock. Separately, analysts at Morgan Stanley reiterated an “overweight” rating on shares of Aetna in a research note to investors on Friday, December 13th. They now have a $83.00 price target on the stock. Finally, analysts at Zacks downgraded shares of Aetna from an “outperform” rating to a “neutral” rating in a research note to investors on Wednesday, November 27th. They now have a $72.00 price target on the stock. Six research analysts have rated the stock with a hold rating, eighteen have issued a buy rating and one has assigned a strong buy rating to the stock. The stock has a consensus rating of “Buy” and an average price target of $73.10.
Aetna Inc (NYSE:AET) is a diversified healthcare benefits company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.